GLP-1 Based Therapeutics: Simultaneously Combating T2DM and Obesity

Frontiers in Neuroscience - Switzerland
doi 10.3389/fnins.2015.00092
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Frontiers Media SA

Related search

Emerging Technologies to Achieve Oral Delivery of GLP-1 and GLP-1 Analogs for Treatment of Type 2 Diabetes Mellitus (T2DM)

Canadian Journal of Biotechnology
2017English

Combating Childhood Obesity

Journal of Child Health Care
Child HealthPediatricsPerinatology
2016English

Do GLP-1-Based Therapies Increase Cancer Risk?

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2013English

GLP 1 and Macrovascular Complications

Journal of Diabetes & Metabolism
2011English

Glucagon, GLP-1 and Thermogenesis

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

GLP-1 and the Gut

Gut
Gastroenterology
2000English

Mediators of Impaired Adipogenesis in Obesity-Associated Insulin Resistance and T2DM

2019English

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

Gut and Liver
HepatologyGastroenterology
2012English

The ‘Springer Gene’: Combating Familial Obesity With Technology and Exercise

American Journal of Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy